Malignant neoplasm

C3_CANCER

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

KELA reimbursements: KELA codes 115|116

15496

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

15496

diagram downward connector

Check minimum number of events None

15496

diagram downward connector
C3_CANCER

Extra metadata

Level in the ICD hierarchy 1
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 60459 32240 28219
Unadjusted prevalence (%) 19.59 18.58 20.90
Mean age at first event (years) 60.84 57.12 65.09

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 3.48 [3.19, 3.79] <1e-100 11068
15 years 0.01 1.64 [1.50, 1.79] 1.4e-27 3696
5 years 0.00 4.09 [3.78, 4.42] <1e-100 3312
1 year 0.00 17.99 [16.05, 20.16] <1e-100 3092

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: C3_CANCER – Malignant neoplasm
GWS hits: 25

Survival analyses between endpoints

Plot

before Malignant neoplasm
after Malignant neoplasm

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Malignant neoplasm